FIELD: medicine.
SUBSTANCE: invention relates to field of medicine, namely to ophthalmology. In order to predict course of adenoviral keratoconjunctivitis, levels of IgG-, IgA-, IgM-antibodies to causative agents of ophthalmotropic persisting infections: type 1 and 2 herpes simplex virus, cytomegalovirus, Epstein-Barr virus, toxoplasma, mycoplasma gominis, ureaplasma urealyticum, mycobacteria tuberculosis. If threshold value of at least one type of antibodies is exceeded 2 and more times to at least one of causative agents, prolonged or torpid course is predicted.
EFFECT: method makes it possible to predict character of course of adenoviral keratoconjunctivitis.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RISK PREDICTION METHOD FOR RECURRENCE OF HERPES-ASSOCIATED EYE DISEASES | 2007 |
|
RU2345366C1 |
| METHOD FOR PREDICTION OF RISK OF CONGENITAL INFECTIONS | 2013 |
|
RU2532382C1 |
| METHOD OF SIMULTANEOUS DETECTION OF ANTIBODIES OF CLASS G TO ANTIGENS OF AGENTS OF TORCH-INFECTIONS USING IMMUNOCHIP | 2014 |
|
RU2545792C2 |
| METHOD FOR DETERMINING ANTIBODY TITERS BY APPLYING IMMUNOENZYME ANALYSIS IN DIAGNOSING VIRAL INFECTIONS | 2002 |
|
RU2212038C1 |
| METHOD OF EARLY DIAGNOSTICS OF INFLAMMATORY DISEASES OF BRAIN AND ITS MENINGES IN TERM NEWBORNS WITH INTRAUTERINE CYTOMEGALOVIRUS-HERPES INFECTION | 2014 |
|
RU2563132C1 |
| METHOD TO DETERMINE ANTIBODIES TO OPPORTUNISTIC INFECTIONS IN LIQUOR OF CHILDREN | 2012 |
|
RU2488822C1 |
| METHOD FOR PREDICTING THE TIGHTENING OF ACUTE NAZOFARINGETIC IN WOMEN WITH REACTIVATION OF CHRONIC MIXED-HERPESVIRUS INFECTION IN THE SECOND TRIMESTER OF PREGNANCY | 2017 |
|
RU2644831C1 |
| METHOD OF DETERMINATION OF COMPLEX OF ETIOLOGICAL FACTORS LEADING TO DEVELOPMENT OF SPECIFIC CHRONIC INFLAMMATORY DISEASES OF ANTERIOR EYE CREST | 2007 |
|
RU2337609C2 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR GENERALISED FORM OF INTRAUTERINE MONO- AND MIXED CYTOMEGALOVIRUS INFECTION IN NEWBORNS | 2013 |
|
RU2553632C1 |
| METHOD OF SELECTING THERAPY OF CHRONIC INFLAMMATORY DISEASES OF EYE SURFACE BASED ON CONTROLLED POTENTIATION OF EXUDATIVE REACTION BY MEANS OF MECHANICAL OR IMMUNE IMPACT | 2009 |
|
RU2421193C2 |
